Evidence map›Paper›PMID 38982088›Full record

ArticleScientific reports2024

Inferring the natural history of HPV from global cancer registries: insights from a multi-country calibration.

Robyn M Stuart, Jamie A Cohen, Romesh G Abeysuriya, Paula Sanz-Leon, Cliff C Kerr, Darcy Rao, Daniel J Klein

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. REBACINWorld journal of surgical oncology · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Robyn M StuartGender Equality Division, Bill & Melinda Gates Foundation, Seattle, WA, USA. info@hpvsim.org.
Jamie A CohenGlobal Health Division, Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle, WA, USA.
Romesh G AbeysuriyaBurnet Institute, Melbourne, VIC, Australia.
Paula Sanz-LeonBrain Modelling Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Cliff C KerrGlobal Health Division, Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle, WA, USA.
Darcy RaoGender Equality Division, Bill & Melinda Gates Foundation, Seattle, WA, USA.
Daniel J KleinGlobal Health Division, Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle, WA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papillomavirus (HPV) is the cause of almost all cases of cervical cancer, a disease that kills some 340,000 women per year. The timeline from initial infection with HPV to the onset of invasive cervical cancer spans decades, and observational studies of this process are limited to settings in which treatment of precancerous lesions was withheld or inadequate. Such studies have been critical for understanding the natural history of HPV. Modeling can shed additional insight on the natural history of HPV, especially across geographical settings with varying prevalence of factors known to affect the host-side immune response to HPV, such as HIV and tobacco use. In this study, we create models for the 30 most populous countries in Sub-Saharan Africa, each with country-specific demographic, and behavioral inputs. We found that it was not possible to fit the data if we assumed that the natural history parameters were exactly identical for all countries, even after accounting for demographic and behavioral differences, but that we could achieve a good fit with the addition of a single immunocompetence parameter for each country. Our results indicate that variation in host immune responses may play a role in explaining the differences in the burden of cervical cancer between countries, which in turn implies a greater need for more geographically diverse data collection to understand the natural history of HPV.

Indexed as

Papillomavirus InfectionsRegistriesUterine Cervical NeoplasmsAdultAfrica South of the SaharaCalibrationFemaleGlobal HealthHumansMiddle AgedPapillomaviridaePrevalence

Identifiers

PMID38982088
PMCPMC11233645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.